IPP Bureau
WuXi STA launches parenteral formulation manufacturing line at Wuxi
By IPP Bureau - December 01, 2022
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
JB Pharma gets USFDA approval for its generic Venlafaxine Extended-Release Tablets
By IPP Bureau - December 01, 2022
This product is based on Osmotic Controlled Release Oral Delivery System technology
Botanical Solution and Croda Pharma inks agreement to accelerate production for GMP QS-21
By IPP Bureau - December 01, 2022
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications.
Akums partners with Leiutis and Biophore for developing products for multiple therapies
By IPP Bureau - December 01, 2022
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
Lonza collaborates with AbTis to extend Bioconjugation capabilities
By IPP Bureau - November 30, 2022
Collaboration to implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox
.png "Cipla launches Leuprolide Acetate Injection Depot ( (22.5 mg)")
Cipla launches Leuprolide Acetate Injection Depot ( (22.5 mg)
By IPP Bureau - November 30, 2022
Leuprolide Acetate Injection Depot contains 22.5 mg of leuprolide acetate for 3- month administration given as a single dose injection.
Briefs: Lupin and GMM Pfaudler
By IPP Bureau - November 30, 2022
The joint venture will help both the parties to further develop the high-margin service business
Biocon Biologics completes acquisition of Viatris' Global Biosimilars Business
By IPP Bureau - November 30, 2022
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology
By IPP Bureau - November 30, 2022
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
Zydus enters into BTA for purchase from Watson Pharma
By IPP Bureau - November 30, 2022
The Business Undertaking of Watson is engaged in the business of developing, manufacturing, marketing and sale of API.
Gland Pharma to buy French pharma company Cenexi
By IPP Bureau - November 30, 2022
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
AstraZeneca’s Dapagliflozin receives CDSCO approval
By IPP Bureau - November 30, 2022
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD
Zydus receives tentative approval from USFDA for Levothyroxine Sodium for Injection
By IPP Bureau - November 29, 2022
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
Infosys Foundation opens second Diabetes Reversal Counselling Centre in Nagpur
By IPP Bureau - November 29, 2022
Through lifestyle modifications, ADORE will assess the progress of patients based on parameters like reduction in blood sugar levels and weight, among others
Lupin's subsidiary MedQuimica acquires rights to nine brands from Bausch Health
By IPP Bureau - November 29, 2022
The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness
